Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: TRAVERE THERAPEUTICS, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-10-10 to 2023-10-13
Current total value of award: $236500
Description: CHENODAL 250MG (CHENODIOL) PHARMACEUTICAL